Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease by Wahrle, Suzanne E et al.




Overexpression of ABCA1 reduces amyloid
deposition in the PDAPP mouse model of
Alzheimer disease
Suzanne E. Wahrle
Washington University School of Medicine in St. Louis
Hong Jiang
Washington University School of Medicine in St. Louis
Maia Pasandanian
Washington University School of Medicine in St. Louis
Jungsu Kim
Washington University School of Medicine in St. Louis
Aimin Li
Washington University School of Medicine in St. Louis
See next page for additional authors
Follow this and additional works at: http://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Wahrle, Suzanne E.; Jiang, Hong; Pasandanian, Maia; Kim, Jungsu; Li, Aimin; Knoten, Amanda; Jain, Sanjay; Hirsch-Reinshagen,
Veronica; Wellington, Cheryl L.; Bales, Kelly R.; Paul, Steven M.; and Holtzman, David M., ,"Overexpression of ABCA1 reduces
amyloid deposition in the PDAPP mouse model of Alzheimer disease." The Journal of Clinical Investigation.118,2. 671-682. (2008).
http://digitalcommons.wustl.edu/open_access_pubs/1587
Authors
Suzanne E. Wahrle, Hong Jiang, Maia Pasandanian, Jungsu Kim, Aimin Li, Amanda Knoten, Sanjay Jain,
Veronica Hirsch-Reinshagen, Cheryl L. Wellington, Kelly R. Bales, Steven M. Paul, and David M. Holtzman
This open access publication is available at Digital Commons@Becker: http://digitalcommons.wustl.edu/open_access_pubs/1587
Research article
	 The	Journal	of	Clinical	Investigation      http://www.jci.org      Volume 118      Number 2      February 2008  671
Overexpression of ABCA1 reduces  
amyloid deposition in the PDAPP  
mouse model of Alzheimer disease
Suzanne E. Wahrle,1 Hong Jiang,1 Maia Parsadanian,1 Jungsu Kim,1 Aimin Li,2  
Amanda Knoten,3 Sanjay Jain,3 Veronica Hirsch-Reinshagen,4  
Cheryl L. Wellington,4 Kelly R. Bales,5 Steven M. Paul,5 and David M. Holtzman1,6,7,8
1Department of Neurology, 2Department of Cell Biology and Physiology, 3John T. Milliken Department of Medicine, Renal Division,  
Washington University School of Medicine, St. Louis, Missouri, USA. 4Department of Pathology and Laboratory Medicine,  
University of British Columbia, Vancouver, British Columbia, Canada. 5Neuroscience Discovery Research, Eli Lilly and Company,  
Lilly Research Laboratories, Indianapolis, Indiana, USA. 6Edward Mallinckrodt Department of Developmental Biology,  




































































Downloaded on August 12, 2013.   The Journal of Clinical Investigation.   More information at  www.jci.org/articles/view/33622
research article











































Creation and characterization of PrP-mAbca1 Tg mice. 
Thirteen founders tested positive for the PrP-mAbca1 
transgene by PCR. One founder died before breed-




























Characterization of 3-month-old PrP-mAbca1 mice. (A) Levels of ABCA1 in the cortex 
of 5 different lines of PrP-mAbca1 mice (lines D, E, L, J, and G) were visualized by 
Western blotting. RIPA lysates were made from cortex, and equal amounts of total pro-
tein (10 μg) were electrophoresed. Western blotting of ABCA1 was performed using the 
HJ1 antibody. Samples from Tg (+) and non-Tg mice (–) were compared. Liver lysates 
from Abca1+/+ and Abca1–/– mice were used as positive and negative controls, respec-
tively. The fold difference in ABCA1 overexpression was estimated by diluting the Tg 
sample until the level of ABCA1 equaled that of the non-Tg sample. (B) ABCA1 expres-
sion in multiple brain regions was assessed by Western blotting in PrP-mAbca1 line E 
mice. (C) ABCA1 expression in major body tissues was examined in mice expressing 
no ABCA1 (bottom panel), the PrP-mAbca1 transgene with no endogenous ABCA1 (the 
top panel), and endogenous ABCA1 (middle panel). Liver lysates from Abca1+/+ and 
Abca1–/– mice were used as positive and negative controls, respectively.
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Spermatogenesis defects in 3-month-old PrP-mAbca1 line E Tg mice. (A) Testes from PrP-mAbca1 line E mice (n = 5) and non-Tg mice (n = 6) 
were dissected and weighed. (B) A representative testis from a Tg mouse and a non-Tg mouse. Scale bar: 5 mm. (C) H&E-stained sections 
show normal testicular histology in non-Tg mice (top left panel) and marked degeneration of seminiferous tubules of Tg mice (top right panel), 
with several multinucleated giant cells (arrowheads) present in almost every tubule compared with their rare occurrence in non-Tg mice. No 
elongated spermatids were present in testes from Tg mice. TUNEL staining shows occasional apoptotic cells in testes from non-Tg mice (bottom 
left panel) and frequent apoptotic cells in testes from Tg mice (bottom right panel). Scale bar: 50 μm for the top panels and 100 μm for the bottom 
panels. (D) Quantification of TUNEL staining in the testes of Tg (n = 4) and non-Tg littermate control mice (n = 4). (E) Sections of testes from Tg 
(n = 3) and non-Tg littermate control mice (n = 4) underwent immunohistochemical staining with an anti-GCNA1 antibody that stains germ cells. 
The number of GCNA1-positive cells per tubule was tabulated. Statistical analyses of differences between Tg and non-Tg mice were performed 
using 2-tailed Student’s t test. **P < 0.01; ****P < 0.0001.
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Aβ staining and thioflavine S fluorescence in the brains of 12-month-old PDAPP/Abca1 
line E mice. (A) Sections of brain from PDAPP/Abca1 non-TG mice, PDAPP/Abca1 line 
E mice, and PDAPP/Apoe–/– mice were stained for Aβ using the 3D6 antibody. True amy-
loid was visualized by thioflavine S fluorescence. The arrows shown in the middle panels 
indicate the upper and lower limits of the hilus of the dentate gyrus. Scale bar: 125 μm 
for the top and bottom panels and 250 μm for the middle panels. (B) Brain sections from 
PDAPP/Abca1 line E mice were immunostained with an antibody against the microglial 
marker CD45. Scale bar: 625 μm for all panels.
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Aβ load and thioflavine S–positive plaque load in 12-month-old PDAPP/Abca1 mice. (A and B) Using stereological methods, Aβ staining and thio-
flavine S fluorescence were quantified in the cortex, hippocampus, and 2 subregions of the hippocampus (molecular layer and hilus of the dentate 
gyrus) of PDAPP/Abca1 line E mice. (C and D) Thioflavine S fluorescence was quantified in the cortex and hippocampus of PDAPP/Abca1 line 
D, line E, and line J mice. n = 10 for all groups. Statistical analyses of differences between Tg and non-Tg mice were performed using the Mann-
Whitney U test. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
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Aβ as detected by ELISA in the hip-
pocampus of PDAPP/Abca1 mice. 
(A–D) Aβ was serially extracted 
from the hippocampus using car-
bonate and guanidine buffers and 
measured by ELISA. The Aβ in the 
carbonate and guanidine extracts 
was summed, and total Aβ40 and 
Aβ42 ares represented. TP, total 
protein in the tissue lysate. (A 
and B) Aβ in the hippocampus of 
3-month-old mice from PDAPP/
Abca1 lines D and E, respectively. 
n = 11 in all groups. (C and D) Aβ 
in the hippocampus of 12-month-old 
mice from PDAPP/Abca1 lines D 
and E, respectively. n = 10–14 in all 
groups. Statistical analyses of differ-
ences between Tg and non-Tg mice 
were performed using 2-tailed Stu-
dent’s t test. *P < 0.05; **P < 0.01; 
***P < 0.001; ****P < 0.0001. (E) 
Levels of APP and APP C-terminal 
fragments in hippocampus from 
PDAPP/Abca1 line E mice were 
visualized by Western blotting. n = 7 
for both groups. β-Tubulin was used 
as a loading control. Quantification 
of the APP and CTF bands using 
image analysis software revealed 
no significant differences between 
PDAPP/Abca1 Tg and PDAPP/
Abca1 non-Tg mice.
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Aβ levels in brain extracts as measured by ELISA
	 Carbonate	 Guanidine	 Total




–, n = 11 0.36 ± 0.09A 0.34 ± 0.04B 1.39 ± 0.30 2.25 ± 0.54A 1.75 ± 0.35A 2.59 ± 0.55A
+, n = 11 0.49 ± 0.13 0.47 ± 0.15 1.62 ± 0.35 2.97 ± 0.91 2.12 ± 0.44 3.44 ± 0.98
Line E
–, n = 11 0.32 ± 0.07B 0.44 ± 0.10A 0.80 ± 0.23B 1.68 ± 0.36C 1.12 ± 0.26B 2.11 ± 0.37D
+, n = 11 0.41 ± 0.05 0.57 ± 0.12 1.32 ± 0.46 3.17 ± 0.52 1.73 ± 0.48 3.73 ± 0.56
Cortex
Line D
–, n = 11 0.19 ± 0.05 0.34 ± 0.07 0.45 ± 0.07 0.89 ± 0.12 0.64 ± 0.11 1.23 ± 0.13
+, n = 11 0.23 ± 0.09 0.35 ± 0.08 0.05 ± 0.07 0.86 ± 0.13 0.73 ± 0.12 1.21 ± 0.11
Line E
–, n = 11 0.35 ± 0.05 0.34 ± 0.04 0.26 ± 0.04C 0.97 ± 0.16D 0.60 ± 0.07C 1.31 ± 0.15D




–, n = 12 0.86 ± 0.25C 2.03 ± 0.47D 21.1 ± 5.2D 260 ± 73D 22.0 ± 5.4D 262 ± 73D
+, n = 12 0.49 ± 0.13 0.93 ± 0.36 9.14 ± 4.72 103 ± 73 9.63 ± 4.81 104 ± 73
Line E
–, n = 14  0.59 ± 0.12B 1.52 ± 0.44D 12.0 ± 2.6D 132 ± 43 12.6 ± 2.7D 134 ± 44C
+, n = 10 0.46 ± 0.08 0.55 ± 0.41 2.34 ± 0.31 42.3 ± 65.8 2.80 ± 0.33 42.8 ± 66.2
Cortex
Line D
–, n = 12 0.47 ± 0.15B 1.42 ± 0.49C 5.95 ± 2.16C 81.0 ± 34.3C 6.42 ± 2.27C 81.0 ± 34.3C
+, n = 12 0.31 ± 0.10 0.70 ± 0.26 3.29 ± 0.84 33.8 ± 11.1 3.60 ± 0.86 33.8 ± 11.1
Line E
–, n = 14 0.34 ± 0.07 0.83 ± 0.24D 3.51 ± 1.15D 46.0 ± 22.4B 3.84 ± 1.18D 46.9 ± 22.5B
+, n = 10 0.29 ± 0.05 0.40 ± 0.15 1.38 ± 0.18 15.6 ± 21.9 1.66 ± 0.19 16.0 ± 22.0
Units are ng of Aβ per mg of total protein. Statistical analyses of differences between Tg and non-Tg mice were performed using 2-tailed Student’s t test. 
No footnote, not significant; AP < 0.05; BP < 0.01; CP < 0.001; DP < 0.0001.
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Levels of apoE in the hippocampus, cortex, and CSF of 3-month-old PrP-mAbca1 Tg mice. (A and B) apoE was serially extracted from brain 
tissue using carbonate and guanidine buffers and measured by ELISA. The apoE in the carbonate and guanidine extracts was summed, and 
total apoE is represented in A and B. (C) CSF was diluted, and apoE levels were measured by ELISA. (D) RNA was extracted from the hippo-
campus and cortex of PrP-mAbca1 line E mice. Real-time quantitative RT-PCR was performed for mouse apoE mRNA and total rRNA. Mouse 
apoE mRNA was normalized to total rRNA. (A–D) For all groups, the n = 7–9. Tg and non-Tg samples from the same line were processed 
at the same time. Statistical analyses of differences between Tg and non-Tg mice were performed using 2-tailed Student’s t test. *P < 0.05; 
**P < 0.01; ***P < 0.001; ****P < 0.0001.
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Analysis of apoE-containing lipoprotein particles derived from PrP-mAbca1 line E mice. (A) CSF (2 μl) from 3-month-old PrP-mAbca1 line E 
mice was run on a nondenaturing gradient gel, and Western blot analysis for mouse apoE was performed. (B) Media conditioned by primary 
astrocytes derived from PrP-mAbca1 line E mice was run on a nondenaturing gradient gel, and Western blot analysis for mouse apoE was per-
formed. Samples containing equal amounts of apoE were loaded. (C and D) Primary astrocytes derived from PrP-mAbca1 line E mice secreted 
apoE-containing lipoprotein particles into the media over 72 hours. Lipoprotein particles in the ACM were separated by size using gel filtration 
chromatography. The levels of apoE and cholesterol were then measured in the fractions and normalized to total protein in the cell pellet. n = 3 
for non-Tg and n = 5 for Tg. (E) The amount of cholesterol and apoE in lipoprotein fractions 20–50 was totaled, and lipoprotein cholesterol was 
divided by lipoprotein apoE. Two-tailed Student’s t test was performed to evaluate the statistical significance of differences between particles 
from Tg and non-Tg mice. ****P < 0.0001.
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Comparison of lipoprotein receptors and lipoproteins in PrP-mAbca1 
line E Tg versus non-Tg mice. (A) Samples of cortex from 3-month-old 
mice were lysed in RIPA buffer. Equal amounts of total protein from 
each mouse were loaded into each well of the gel and then assessed 
by Western blotting for LDLR, LRP, apoJ, apoA-I, and tubulin. Three 
representative lanes are shown for Tg and non-Tg mice. (B) Quantita-
tive analysis of Western blots was performed using Kodak Image Sta-
tion software, with n = 3–6 per group. ****P < 0.0001.
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